Sanofi (LON:0O59)

Market Cap	103.84B
Revenue (ttm)	36.62B
Net Income (ttm)	4.60B
Shares Out	n/a
EPS (ttm)	3.67
PE Ratio	22.58
Forward PE	n/a
Dividend	3.23 (3.11%)
Ex-Dividend Date	May 12, 2025

Volume	243,858
Average Volume	779,160
Open	104.12
Previous Close	104.01
Day's Range	103.58 - 105.52
52-Week Range	70.18 - 87.94
Beta	0.46
RSI	35.91
Earnings Date	Apr 24, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O59

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR